NLSP - .5949 Pre-market .705/.71 NLS Pharmaceutics Announces Positive Opinion From European Regulators To Grant Orphan Drug Designation For Mazindol ER In Idiopathic Hypersomnia https://stockcharts.com/h-sc/ui?s=nlsp